Cargando…
A Pituitary Carcinoma Patient With Cerebrospinal Fluid Dissemination Showing a Good Response to Temozolomide Combined With Whole-Brain and Spinal Cord Radiotherapy: A Case Report and Literature Review
Pituitary carcinoma (PC) is extremely rare, with its incidence only accounting for 0.1%-0.2% of pituitary tumor (PT). Existing histological features, including invasiveness, cellular pleomorphism, nuclear atypia, mitosis, necrosis, etc., can be observed in pituitary adenoma (PA), invasive PA (IPA) a...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321396/ https://www.ncbi.nlm.nih.gov/pubmed/35903687 http://dx.doi.org/10.3389/fonc.2022.890458 |
_version_ | 1784756034830598144 |
---|---|
author | Du, Peng Wu, Xuefan Lv, Kun Xiong, Ji Geng, Daoying |
author_facet | Du, Peng Wu, Xuefan Lv, Kun Xiong, Ji Geng, Daoying |
author_sort | Du, Peng |
collection | PubMed |
description | Pituitary carcinoma (PC) is extremely rare, with its incidence only accounting for 0.1%-0.2% of pituitary tumor (PT). Existing histological features, including invasiveness, cellular pleomorphism, nuclear atypia, mitosis, necrosis, etc., can be observed in pituitary adenoma (PA), invasive PA (IPA) and PC. Invasion is not the basis for the diagnosis of PC. The diagnosis of PC is often determined after the metastases are found, hence early diagnosis is extraordinarily difficult. Owing to the conventional treatment for PC may not be effective, a large portion of patients survived less than one year after diagnosis. Therefore, it is of great significance to find an efficacious treatment for PC. We report a rare case of sparsely granulated somatotroph carcinoma with cerebrospinal fluid dissemination showing a favorable treatment response to temozolomide (TMZ) combined with whole-brain and spinal cord radiotherapy. |
format | Online Article Text |
id | pubmed-9321396 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93213962022-07-27 A Pituitary Carcinoma Patient With Cerebrospinal Fluid Dissemination Showing a Good Response to Temozolomide Combined With Whole-Brain and Spinal Cord Radiotherapy: A Case Report and Literature Review Du, Peng Wu, Xuefan Lv, Kun Xiong, Ji Geng, Daoying Front Oncol Oncology Pituitary carcinoma (PC) is extremely rare, with its incidence only accounting for 0.1%-0.2% of pituitary tumor (PT). Existing histological features, including invasiveness, cellular pleomorphism, nuclear atypia, mitosis, necrosis, etc., can be observed in pituitary adenoma (PA), invasive PA (IPA) and PC. Invasion is not the basis for the diagnosis of PC. The diagnosis of PC is often determined after the metastases are found, hence early diagnosis is extraordinarily difficult. Owing to the conventional treatment for PC may not be effective, a large portion of patients survived less than one year after diagnosis. Therefore, it is of great significance to find an efficacious treatment for PC. We report a rare case of sparsely granulated somatotroph carcinoma with cerebrospinal fluid dissemination showing a favorable treatment response to temozolomide (TMZ) combined with whole-brain and spinal cord radiotherapy. Frontiers Media S.A. 2022-07-12 /pmc/articles/PMC9321396/ /pubmed/35903687 http://dx.doi.org/10.3389/fonc.2022.890458 Text en Copyright © 2022 Du, Wu, Lv, Xiong and Geng https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Du, Peng Wu, Xuefan Lv, Kun Xiong, Ji Geng, Daoying A Pituitary Carcinoma Patient With Cerebrospinal Fluid Dissemination Showing a Good Response to Temozolomide Combined With Whole-Brain and Spinal Cord Radiotherapy: A Case Report and Literature Review |
title | A Pituitary Carcinoma Patient With Cerebrospinal Fluid Dissemination Showing a Good Response to Temozolomide Combined With Whole-Brain and Spinal Cord Radiotherapy: A Case Report and Literature Review |
title_full | A Pituitary Carcinoma Patient With Cerebrospinal Fluid Dissemination Showing a Good Response to Temozolomide Combined With Whole-Brain and Spinal Cord Radiotherapy: A Case Report and Literature Review |
title_fullStr | A Pituitary Carcinoma Patient With Cerebrospinal Fluid Dissemination Showing a Good Response to Temozolomide Combined With Whole-Brain and Spinal Cord Radiotherapy: A Case Report and Literature Review |
title_full_unstemmed | A Pituitary Carcinoma Patient With Cerebrospinal Fluid Dissemination Showing a Good Response to Temozolomide Combined With Whole-Brain and Spinal Cord Radiotherapy: A Case Report and Literature Review |
title_short | A Pituitary Carcinoma Patient With Cerebrospinal Fluid Dissemination Showing a Good Response to Temozolomide Combined With Whole-Brain and Spinal Cord Radiotherapy: A Case Report and Literature Review |
title_sort | pituitary carcinoma patient with cerebrospinal fluid dissemination showing a good response to temozolomide combined with whole-brain and spinal cord radiotherapy: a case report and literature review |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321396/ https://www.ncbi.nlm.nih.gov/pubmed/35903687 http://dx.doi.org/10.3389/fonc.2022.890458 |
work_keys_str_mv | AT dupeng apituitarycarcinomapatientwithcerebrospinalfluiddisseminationshowingagoodresponsetotemozolomidecombinedwithwholebrainandspinalcordradiotherapyacasereportandliteraturereview AT wuxuefan apituitarycarcinomapatientwithcerebrospinalfluiddisseminationshowingagoodresponsetotemozolomidecombinedwithwholebrainandspinalcordradiotherapyacasereportandliteraturereview AT lvkun apituitarycarcinomapatientwithcerebrospinalfluiddisseminationshowingagoodresponsetotemozolomidecombinedwithwholebrainandspinalcordradiotherapyacasereportandliteraturereview AT xiongji apituitarycarcinomapatientwithcerebrospinalfluiddisseminationshowingagoodresponsetotemozolomidecombinedwithwholebrainandspinalcordradiotherapyacasereportandliteraturereview AT gengdaoying apituitarycarcinomapatientwithcerebrospinalfluiddisseminationshowingagoodresponsetotemozolomidecombinedwithwholebrainandspinalcordradiotherapyacasereportandliteraturereview AT dupeng pituitarycarcinomapatientwithcerebrospinalfluiddisseminationshowingagoodresponsetotemozolomidecombinedwithwholebrainandspinalcordradiotherapyacasereportandliteraturereview AT wuxuefan pituitarycarcinomapatientwithcerebrospinalfluiddisseminationshowingagoodresponsetotemozolomidecombinedwithwholebrainandspinalcordradiotherapyacasereportandliteraturereview AT lvkun pituitarycarcinomapatientwithcerebrospinalfluiddisseminationshowingagoodresponsetotemozolomidecombinedwithwholebrainandspinalcordradiotherapyacasereportandliteraturereview AT xiongji pituitarycarcinomapatientwithcerebrospinalfluiddisseminationshowingagoodresponsetotemozolomidecombinedwithwholebrainandspinalcordradiotherapyacasereportandliteraturereview AT gengdaoying pituitarycarcinomapatientwithcerebrospinalfluiddisseminationshowingagoodresponsetotemozolomidecombinedwithwholebrainandspinalcordradiotherapyacasereportandliteraturereview |